| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |